My dad inspired me to become a doctor. And now, when I work with children and families, I treat them like they are part of my own family.
As a pediatric orthopedist, I specialize in caring for children with cancer and in providing joint replacement surgery.
I want families to know that I am always available to them. I make myself accessible to answer their questions or talk about whatever is on their mind.
My research focuses on cancer survival in children.
When I’m not at work I enjoy playing golf and spending time with my family.
BS: Biology, University of Richmond, VA, 1987,
MD: Medical College of Virginia, Richmond, VA, 1991,
Internship: General Surgery Intern, University of Cincinnati, Cincinnati, OH, 1992,
Residency: General surgery, University of Cincinnati, College of Medicine, 1993,
Residency: Orthopaedic surgery, University of Cincinnati. College of Medicine, 1998,
Fellowship: Orthopaedic research, Department of Aerospace Engineering, Noyes-Giannestras Biomechanics Lab, University of Cincinnati, 1994,
Fellowship: Bone and Soft Tissue Sarcoma Management, Orthopaedic Oncology, Harvard University, Massachusetts General Hospital and Boston, Children’s Hospital, 1999,
Certifications: American Board of Orthopaedic Surgeons
Orthopaedic oncology (sarcoma surgery) and joint replacement surgery
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trials. Cancer. 2025; 131(12):e35929.
Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion-Positive Solid Tumors (Children's Oncology Group ADVL1823). Journal of Clinical Oncology. 2025; 43(10):1188-1197.
Outcome of children and young adults with localized extremity rhabdomyosarcoma treated on Children's Oncology Group trials. Journal of Clinical Oncology. 2024; 42(16_suppl):10006-10006.
Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A. Journal of Clinical Oncology. 2023; 41(16_suppl):10008-10008.
Pediatric and Young Adult Image-Guided Percutaneous Bone Biopsy-A New Standard of Care? Annals of Surgical Oncology. 2023; 30(6):3658-3665.
ASO Visual Abstract: Pediatric and Young Adult Image-Guided Percutaneous Bone Biopsy-A New Standard of Care? Annals of Surgical Oncology. 2023; 30(6):3667.
ASO Author Reflections: Minimizing Time in Hospital via Bone Biopsy or Other Means. Annals of Surgical Oncology. 2023; 30(6):3666.
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology. Journal of Surgical Oncology. 2023; 127(5):871-881.
Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial. JAMA Oncology. 2022; 8(3):345-353.
Novel ARHGAP23-FER fusion in a metastatic spindle cell-predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib. Cancer. 2021; 127(22):4124-4130.
Joel I. Sorger, MD, Katherine A. S. Auger, MD, MSc ...8/11/2020
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey